A novel peptide-based Tau aggregation inhibitor as a potential therapeutic for Alzheimer’s disease and other Tauopathies

Published in Alzheimer s & Dementia · View the paper (DOI)

Researchers have developed a peptide inhibitor called RI-AG03 that effectively prevents Tau protein aggregation in lab and fruit fly studies. The breakthrough targets both major aggregation-promoting 'hotspots' of the Tau protein, potentially paving the way for more effective treatments for neurodegenerative diseases.

A novel peptide-based Tau aggregation inhibitor as a potential therapeutic for Alzheimer’s disease and other Tauopathies

Coverage from 2 institutions